Vanguard Personalized Indexing Management, LLC Glycomimetics Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 16,936 shares of GLYC stock, worth $3,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,936
Previous 26,304
35.61%
Holding current value
$3,556
Previous $6,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GLYC
# of Institutions
38Shares Held
30.8MCall Options Held
80.9KPut Options Held
20.8K-
Bvf Inc San Francisco, CA9.54MShares$2 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$1.13 Million0.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$1.07 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$630,0000.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$560,7430.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $11M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...